Medication overuse and chronic migraine: a critical review according to clinical pharmacology

被引：30

作者：

Ferrari, Anna ^{[1
]}

Baraldi, Carlo ^{[2
]}

Sternieri, Emilio ^{[2
]}

机构：

[1] Univ Modena & Reggio Emilia, Headache & Drug Abuse Res Ctr, Dept Diagnost Clin & Publ Hlth Med, I-41124 Modena, Italy

[2] Univ Modena & Reggio Emilia, Div Toxicol & Clin Pharmacol, I-41124 Modena, Italy

来源：

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2015年 / 11卷 / 07期

关键词：

chronic migraine; drug; headache; medication-overuse headache; migraine; prevention; prophylaxis; treatment; CHRONIC DAILY HEADACHE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SEROTONIN REUPTAKE INHIBITORS; CEREBRAL-BLOOD-FLOW; QUALITY-OF-LIFE; VALPROIC ACID; RISK-FACTORS; 5-HT1B/1D AGONIST; PHARMACOKINETICS; FEATURES;

D O I：

10.1517/17425255.2015.1043265

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Introduction: Chronic migraine is often complicated by medication-overuse headache (MOH), a headache due to excessive intake of acute medications. Chronic migraine and MOH are serious and disabling disorders. Since chronic migraine derives from the progression of originally episodic migraine, the fundamental therapeutic strategy is prevention. This narrative review describes how to try to prevent the development of MOH and how to manage it once it has appeared. Areas covered: A PubMed database search (from 1988 to January 2015) and a review of published studies on chronic migraine and MOH were conducted. Expert opinion: In spite of progress in migraine treatment, the prevalence of chronic headaches and MOH has not changed in the course of time. Today, a large number of migraine patients have turned to numerous expert physicians and experienced all sorts of prophylactic treatments without decisive benefits. Their condition seems to have crystallized even more as chronic and intractable. This means that to prevent chronification and MOH, we need more effective drugs and better strategies to use them. In particular, we must detect disease biomarkers and predictive factors for drug response that allow for personalized treatment when migraine is still episodic and make analgesic overuse pointless.

引用

页码：1127 / 1144

页数：18

共 153 条

[1] Herbal medication: potential for adverse interactions with analgesic drugs [J].

Abebe, W .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (06) :391-401

[2] The Effect of Daily Caffeine Use on Cerebral Blood Flow: How Much Caffeine can we Tolerate? [J].

Addicott, Merideth A. ;

Yang, Lucie L. ;

Peiffer, Ann M. ;

Burnett, Luke R. ;

Burdette, Jonathan H. ;

Chen, Michael Y. ;

Hayasaka, Satoru ;

Kraft, Robert A. ;

Maldjian, Joseph A. ;

Laurienti, Paul J. .

HUMAN BRAIN MAPPING, 2009, 30 (10) :3102-3114

[3] LORAZEPAM-VALPROATE INTERACTION - STUDIES IN NORMAL SUBJECTS AND ISOLATED-PERFUSED RAT-LIVER [J].

ANDERSON, GD ;

GIDAL, BE ;

KANTOR, ED ;

WILENSKY, AJ .

EPILEPSIA, 1994, 35 (01) :221-225

[4] Behavioral medicine for migraine and medication overuse headache [J].

Andrasik, Frank ;

Buse, Dawn C. ;

Grazzi, Licia .

CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (03) :241-248

[5] OnabotulinumtoxinA for the Treatment of Headache [J].

Ashkenazi, Avi ;

Blumenfeld, Andrew .

HEADACHE, 2013, 53 :54-61

[6] USE OF SINGLE SAMPLE CLEARANCE ESTIMATES OF CYTOCHROME-P450 SUBSTRATES TO CHARACTERIZE HUMAN HEPATIC CYP STATUS INVIVO [J].

BACHMANN, KA ;

JAUREGUI, L .

XENOBIOTICA, 1993, 23 (03) :307-315

[7] Does chronic daily headache arise de novo in association with regular use of analgesics? [J].

Bahra, A ;

Walsh, M ;

Menon, S ;

Goadsby, PJ .

HEADACHE, 2003, 43 (03) :179-190

[8] Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project) [J].

Bendtsen, L. ;

Munksgaard, S. B. ;

Tassorelli, C. ;

Nappi, G. ;

Katsarava, Z. ;

Lainez, M. ;

Leston, J. A. ;

Fadic, R. ;

Spadafora, S. ;

Stoppini, A. ;

Jensen, R. .

CEPHALALGIA, 2014, 34 (06) :426-433

[9] The International Classification of Headache Disorders, 3rd edition (beta version) [J].

Bes, Andre ;

Kunkel, Robert ;

Lance, James W. ;

Nappi, Giuseppe ;

Pfaffenrath, Volker ;

Rose, Frank Clifford ;

Schoenberg, Bruce S. ;

Soyka, Dieter ;

Tfelt-Hansen, Peer ;

Welch, K. Michael A. ;

Wilkinson, Marica ;

Olesen, Jes ;

Bousser, Marie-Germaine ;

Diener, Hans-Christoph ;

Dodick, David ;

First, Michael ;

Goadsby, Peter J. ;

Goebel, Hartmut ;

Lainez, Miguel J. A. ;

Lance, James W. ;

Lipton, Richard B. ;

Nappi, Giuseppe ;

Sakai, Fumihiko ;

Schoenen, Jean ;

Silberstein, Stephen D. ;

Steiner, Timothy J. ;

Olesen, Jes ;

Bendtsen, Lars ;

Dodick, David ;

Ducros, Anne ;

Evers, Stefan ;

First, Michael ;

Goadsby, Peter J. ;

Hershey, Andrew ;

Katsarava, Zaza ;

Levin, Morris ;

Pascual, Julio ;

Russell, Michael B. ;

Schwedt, Todd ;

Steiner, Timothy J. ;

Tassorelli, Cristina ;

Terwindt, Gisela M. ;

Vincent, Maurice ;

Wang, Shuu-Jiun ;

Olesen, J. ;

Evers, S. ;

Charles, A. ;

Hershey, A. ;

Lipton, R. ;

First, M. .

CEPHALALGIA, 2013, 33 (09) :629-808

[10] Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration [J].

Bickel, M. ;

Khaykin, P. ;

Stephan, C. ;

Schmidt, K. ;

Buettner, M. ;

Amann, K. ;

Lutz, T. ;

Gute, P. ;

Haberl, A. ;

Geiger, H. ;

Brodt, H. R. ;

Jung, O. .

HIV MEDICINE, 2013, 14 (10) :633-638

← 1 2 3 4 5 6 7 8 9 10 →